Business
Rafarma Pharmaceuticals (OTC:RAFA) Announces Cooperative Agreement with the St. Petersburg Academy of Pharmaceutical Chemistry
Rafarma Pharmaceuticals (OTC:RAFA) Announces Cooperative Agreement with the St. Petersburg Academy of Pharmaceutical Chemistry.
About this update from Rafarma Pharmaceuticals, Inc. (wy)
[{"type":"text","content":"\n\n\n\nRafarma Pharmaceuticals (OTC:RAFA) Announces Cooperative Agreement with the St. Petersburg Academy of Pharmaceutical Chemistry\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nRafarma Pharmaceuticals (OTC:RAFA) Announces Cooperative Agreement with the St. Petersburg Academy of Pharmaceutical Chemistry\nPR Newswire\nMOSCOW, Feb. 5, 2014\n\n\n\nMOSCOW, Feb. 5, 2014 /PRNewswire/ -- On February 3, 2014, ZAO Rafarma management met with senior faculty members of the St. Petersburg Academy of Pharmaceutical Chemistry to create a long-term cooperative agreement. \n\nRafarma will work with and be able to recruit from the finest pharmaceutical specialists graduating in Russia, as well as having access to the Academy's innovative pharmaceutical research. \n\nThe cooperative agreement is borne out of the initiatives outlined in \"Pharma 2020,\" the Russian National Pharmaceutical Strategy. For the Academy, the agreement creates specialized and tailored educational programs allowing undergraduates exposure to Rafarma's most innovative testing protocols at Rafarma's state-of-the-art facilities under highly-skilled technical supervision.\n\n\"Such cooperative agreements with pharmaceutical higher education continue to raise Rafarma's leadership position in the Russian pharmaceutical industry. We are delighted to have an institution of such extraordinary reputation as a partner,\" commented Rafarma's CEO David Anderson. \n\nAbout Rafarma Pharmaceuticals, Inc. \n\nOperating from a new 270,000 square-foot state-of-the-art manufacturing and distribution facility in Russia, Rafarma Pharmaceuticals produces generic antibiotics and specialty pharmaceuticals in addition to its own line of proprietary products that are approved by the Ministry of Health of Russian Federation. For the last three years, the Russian Government has been highly focused on bolstering the development of the nation's domestic pharmaceutical industry. Rafarma's mission is to work under the auspices of these aggressive federal initiatives to fast-track the modernization of Russia's pharmaceutical industry.\n\...